[开放获取]   儿童鲜红斑痣诊疗专家共识（2025版）

doi:10.35541/cjd.20240452

Abstract

Abstract: 【Abstract】 Port-wine stain （PWS） is the most common type of low-flow capillary malformations in children. PWS often occurs after birth with a predilection for the face and neck, seriously affecting the physical and mental health of patients and the quality of life of their families. Compared with adults, children are in a growth and development stage. PWS-related syndromes can affect extracutaneous organs, but may only present with mild erythema in the early stage, and is liable to result in misdiagnosis or missed diagnosis. Therefore, early recognition is particularly important. Based on the latest Chinese and international research progress and through extensive discussions, the Consensus Development Expert Group on Diagnosis and Treatment of PWS in Chinese Children formulated the consensus on the etiology, pathogenesis, clinical manifestations, laboratory examinations, diagnosis, differential diagnosis, and treatment of, as well as health education for PWS in children, aiming to provide guidance for clinicians on the diagnosis and treatment of PWS.

Key words: Port-wine stain, Child, Diagnosis, Therapy, Expert consensus

The Consensus Development Expert Group on Diagnosis and Treatment of Port-wine Stain in Chinese Children, Pediatric Dermatologist Committee, China Dermatologist Association. Expert consensus on diagnosis and treatment of port-wine stain in children （2025 edition）[J]. Chinese Journal of Dermatology, 2025, 58(5): 396-404.doi:10.35541/cjd.20240452

References ［70］

［1］	马琳, 王华. 儿童皮肤病学［M］. 2版. 北京: 人民卫生出版社, 2024:341⁃342.
［2］	Zhang B, Ma L. Updated classification and therapy of vascular malformations in pediatric patients［J］. Pediatr Investig, 2018,2（2）:119⁃123. doi: 10.1002/ped4.12043.
［3］	Centre for Evidence⁃Based Medicine, University of Oxford. Oxford Centre for Evidence⁃Based Medicine: levels of evidence （March 2009）［EB/OL］.2009［2024⁃03⁃25］. https://www.cebm.ox.ac.uk/resources/levels⁃of⁃vidence/oxford⁃centre⁃for⁃evidence⁃based⁃medicine⁃levels⁃of⁃evidence⁃march⁃2009.
［4］	Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations［J］. BMJ, 2008,336（7650）:924⁃926. doi: 10. 1136/bmj.39489.470347.AD.
［5］	Ustaszewski A, Janowska⁃Głowacka J, Wołyńska K, et al. Genetic syndromes with vascular malformations ⁃ update on molecular background and diagnostics［J］. Arch Med Sci, 2021,17（4）:965⁃991. doi: 10.5114/aoms.2020.93260.
［6］	Orme CM, Boyden LM, Choate KA, et al. Capillary malformation⁃⁃arteriovenous malformation syndrome: review of the literature, proposed diagnostic criteria, and recommendations for management［J］. Pediatr Dermatol, 2013,30（4）:409⁃415. doi: 10.1111/pde.12112.
［7］	Yu L, Qin K, Deng X, et al. Epidemiological study of capillary malformation among 7299 infants under 1 year of age in China［J］. J Eur Acad Dermatol Venereol, 2023,37（3）:627⁃632. doi: 10.1111/jdv.18767.
［8］	Zhang B, He R, Xu Z, et al. Somatic mutation spectrum of a Chinese cohort of pediatrics with vascular malformations［J］. Orphanet J Rare Dis, 2023,18（1）:261. doi: 10.1186/s13023⁃023⁃02860⁃w.
［9］	张斌, 何瑞, 宋俐, 等. 儿童复杂脉管畸形的分子诊断和靶向治疗的研究进展［J］. 中华预防医学杂志, 2023,57（9）:1481⁃1488. doi: 10.3760/cma.j.cn112150⁃20220930⁃00940.
［10］	Tan W, Wang J, Zhou F, et al. Coexistence of Eph receptor B1 and ephrin B2 in port⁃wine stain endothelial progenitor cells contributes to clinicopathological vasculature dilatation［J］. Br J Dermatol, 2017,177（6）:1601⁃1611. doi: 10.1111/bjd.15716.
［11］	Williams J, Brasch HD, Bockett N, et al. Embryonic stem cell⁃like population in hypertrophic portwine stain［J/OL］. J Vasc Anom, 2021,2（1）:e006. doi: 10.1097/JOVA.0000000000000006.
［12］	Nguyen V, Gao C, Hochman ML, et al. Endothelial cells differentiated from patient dermal fibroblast⁃derived induced pluripotent stem cells resemble vascular malformations of port⁃wine birthmark［J］. Br J Dermatol, 2023,189（6）:780⁃783. doi: 10.1093/bjd/ljad330.
［13］	Nguyen V, Kravitz J, Gao C, et al. Perturbations of glutathione and sphingosine metabolites in port wine birthmark patient⁃derived induced pluripotent stem cells［J］. Metabolites, 2023,13（9）:983. doi: 10.3390/metabo13090983.
［14］	Bolognia J, Cerroni L, Schaffer JV. Dermatology［M］. 4th. Amsterdam: Elservier, 2018:1810.
［15］	Saliba E, Yumeen S, Tannous Z. Acquired port⁃wine stains: a report of two cases and review of the literature［J］. J Cosmet Dermatol, 2023,22（3）:945⁃948. doi: 10.1111/jocd.15526.
［16］	Piaserico S, Belloni Fortina A. Posttraumatic port⁃wine stain in a 4⁃year⁃old girl: Fegeler syndrome［J］. Pediatr Dermatol, 2004,21（2）:131⁃133. doi: 10.1111/j.0736⁃8046.2004.21209.x.
［17］	Hoque S, Holden C. Acquired port wine stain following oral isotretinoin［J］. Clin Exp Dermatol, 2005,30（5）:587⁃588. doi: 10.1111/j.1365⁃2230.2005.01805.x.
［18］	Lee JJ, Lee JC, Kim BS, et al. A comparison of acquired port⁃wine stain with congenital port⁃wine stain using an image analyzer［J］. Ann Dermatol, 2008,20（1）:1⁃5. doi: 10.5021/ad. 2008.20.1.1.
［19］	Nussbaumer⁃Ochsner Y, Spinas G. Dermatological sequela of a car accident: acquired port⁃wine stain （Fegeler syndrome）［J］. BMJ Case Rep, 2015,2015:bcr2015210860. doi: 10.1136/bcr⁃2015⁃210860.
［20］	Seremet S, Benar EB, Afsar FS, et al. A case of acquired port wine stain: an association with repeated sunburn?［J］. Int J Dermatol, 2016,55（10）:e544⁃e546. doi: 10.1111/ijd.13332.
［21］	Stephens MR, Putterman E, Yan AC, et al. Acquired port⁃wine stains in six pediatric patients［J］. Pediatr Dermatol, 2020,37（1）:93⁃97. doi: 10.1111/pde.14019.
［22］	Rozas⁃Muñoz E, Frieden IJ, Roé E, et al. Vascular stains: proposal for a clinical classification to improve diagnosis and management［J］. Pediatr Dermatol, 2016,33（6）:570⁃584. doi: 10.1111/pde.12939.
［23］	Bichsel C, Bischoff J. A somatic missense mutation in GNAQ causes capillary malformation［J］. Curr Opin Hematol, 2019,26（3）:179⁃184. doi: 10.1097/MOH.0000000000000500.
［24］	Zhang B, He R, Wu R, et al. Somatic GNA11/GNAQ variants in a cohort of Chinese children with phakomatosis pigmentovas⁃cularis［J］. Pediatr Investig, 2024,8（2）:117⁃125. doi: 10.1002/ped4.12424.
［25］	Wang X, Suo H, Gao Y, et al. Correlation between the hemoporfin⁃mediated photodynamic treatment response and the dermoscopy vascular pattern in patients with a port⁃wine stain: a prospective study［J］. J Eur Acad Dermatol Venereol, 2020,34（12）:2795⁃2801. doi: 10.1111/jdv.16596.
［26］	胡燕燕, 姜倩, 陈柳青, 等. 反射式共聚焦显微镜在海姆泊芬光动力疗法治疗紫红型鲜红斑痣疗效评估中的应用［J］. 中华皮肤科杂志, 2021,54（4）:342⁃346. doi: 10.35541/cjd.2020 0434.
［27］	Wang X, Fu Y, Liu Y, et al. Non⁃invasive detection technology in port⁃wine stain treatment［J］. Chin Med J （Engl）, 2022,135（21）:2535⁃2537. doi: 10.1097/CM9.0000000000002124.
［28］	Fusano M, Bencini PL. Capillaroscopy and reflectance confocal microscopy characterization of refractory port⁃wine stains［J］. Lasers Med Sci, 2021,36（2）:407⁃412. doi: 10.1007/s10103⁃020⁃03084⁃1.
［29］	Sabeti S, Ball KL, Burkhart C, et al. Consensus statement for the management and treatment of port⁃wine birthmarks in Sturge⁃Weber syndrome［J］. JAMA Dermatol, 2021,157（1）:98⁃104. doi: 10.1001/jamadermatol.2020.4226.
［30］	McCuaig CC. Update on classification and diagnosis of vascular malformations［J］. Curr Opin Pediatr, 2017,29（4）:448⁃454. doi: 10.1097/MOP.0000000000000518.
［31］	Luks VL, Kamitaki N, Vivero MP, et al. Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA［J］. J Pediatr, 2015,166（4）:1048⁃1054.e1⁃5. doi: 10.1016/j.jpeds.2014.12.069.
［32］	Hughes M, Hao M, Luu M. PIK3CA vascular overgrowth syndromes: an update［J］. Curr Opin Pediatr, 2020,32（4）:539⁃546. doi: 10.1097/MOP.0000000000000923.
［33］	Garzon MC, Huang JT, Enjolras O, et al. Vascular malformations. Part Ⅱ: associated syndromes［J］. J Am Acad Dermatol, 2007,56（4）:541⁃564. doi: 10.1016/j.jaad.2006.05.066.
［34］	Valdivielso⁃Ramos M, Martin⁃Santiago A, Azaña JM, et al. Capillary malformation⁃arteriovenous malformation syndrome: a multicentre study［J］. Clin Exp Dermatol, 2021,46（2）:300⁃305. doi: 10.1111/ced.14428.
［35］	Lee MS, Liang MG, Mulliken JB. Diffuse capillary malformation with overgrowth: a clinical subtype of vascular anomalies with hypertrophy［J］. J Am Acad Dermatol, 2013,69（4）:589⁃594. doi: 10.1016/j.jaad.2013.05.030.
［36］	乌日嘎, 李丽, 尉莉, 等. 色素血管性斑痣性错构瘤病的研究现状与探索［J］. 中国皮肤性病学杂志, 2022,36（4）:367⁃370. doi: 10.13735/j.cjdv.1001⁃7089.202101189.
［37］	乌日嘎, 何瑞, 张斌, 等. 合并Klippel⁃Trenaunay综合征及Sturge⁃Weber综合征的色素血管性斑痣性错构瘤病1例［J］. 中华皮肤科杂志, 2022,55（6）:540⁃541. doi: 10.35541/cjd. 20220006.
［38］	Floria M, Năfureanu ED, Iov DE, et al. Hereditary hemorrhagic telangiectasia and arterio⁃venous malformations⁃from diagnosis to therapeutic challenges［J］. J Clin Med, 2022,11（9）:2634. doi: 10.3390/jcm11092634.
［39］	Parrot A, Barral M, Amiot X, et al. Hereditary hemorrhagic telangiectasia［J］. Rev Mal Respir, 2023,40（5）:391⁃405. doi: 10.1016/j.rmr.2023.02.007.
［40］	Brightman LA, Geronemus RG, Reddy KK. Laser treatment of port⁃wine stains［J］. Clin Cosmet Investig Dermatol, 2015,8:27⁃33. doi: 10.2147/CCID.S53118.
［41］	Zhu J, Yu W, Wang T, et al. Less is more: similar efficacy in three sessions and seven sessions of pulsed dye laser treatment in infantile port⁃wine stain patients［J］. Lasers Med Sci, 2018,33（8）:1707⁃1715. doi: 10.1007/s10103⁃018⁃2525⁃6.
［42］	Chang CJ, Hsiao YC, Mihm MC Jr, et al. Pilot study examining the combined use of pulsed dye laser and topical imiquimod versus laser alone for treatment of port wine stain birthmarks［J］. Lasers Surg Med, 2008,40（9）:605⁃610. doi: 10.1002/lsm.20716.
［43］	Chapas AM, Eickhorst K, Geronemus RG. Efficacy of early treatment of facial port wine stains in newborns: a review of 49 cases［J］. Lasers Surg Med, 2007,39（7）:563⁃568. doi: 10.1002/lsm.20529.
［44］	Morelli JG, Weston WL, Huff JC, et al. Initial lesion size as a predictive factor in determining the response of port⁃wine stains in children treated with the pulsed dye laser［J］. Arch Pediatr Adolesc Med, 1995,149（10）:1142⁃1144. doi: 10.1001/archpedi. 1995.02170230096014.
［45］	Nguyen CM, Yohn JJ, Huff C, et al. Facial port wine stains in childhood: prediction of the rate of improvement as a function of the age of the patient, size and location of the port wine stain and the number of treatments with the pulsed dye （585 nm） laser［J］. Br J Dermatol, 1998,138（5）:821⁃825. doi: 10.1046/j.1365⁃2133.1998.02219.x.
［46］	Bajaj S, Tao J, Hashemi DA, et al. Weekly pulsed dye laser treatments for port⁃wine birthmarks in infants［J］. JAMA Dermatol, 2024,160（6）:606⁃611. doi: 10.1001/jamadermatol. 2024.0293.
［47］	Sivarajan V, MacKay IR. The relationship between location, color, and vessel structure within capillary vascular malformations［J］. Ann Plast Surg, 2004,53（4）:378⁃381. doi: 10.1097/01.sap.0000125498.11585.ab.
［48］	Yu W, Ma G, Qiu Y, et al. Why do port⁃wine stains （PWS） on the lateral face respond better to pulsed dye laser （PDL） than those located on the central face?［J］. J Am Acad Dermatol, 2016,74（3）:527⁃535. doi: 10.1016/j.jaad.2015.08.026.
［49］	Savas JA, Ledon JA, Franca K, et al. Pulsed dye laser⁃resistant port⁃wine stains: mechanisms of resistance and implications for treatment［J］. Br J Dermatol, 2013,168（5）:941⁃953. doi: 10. 1111/bjd.12204.
［50］	Kaur Hora M, Choudhary N, Agrawal S, et al. Evaluation of the efficacy and safety profile of long⁃pulsed 1064 Neodymium:Yttrium⁃Aluminum⁃Garnet （Nd:YAG） laser in hemangioma and vascular malformation in darker skin types［J］. Cureus, 2022,14（6）:e25742. doi: 10.7759/cureus.25742.
［51］	Zhong SX, Liu YY, Yao L, et al. Clinical analysis of port⁃wine stain in 130 Chinese patients treated by long⁃pulsed 1064⁃nm Nd: YAG laser［J］. J Cosmet Laser Ther, 2014,16（6）:279⁃283. doi: 10.3109/14764172.2014.946052.
［52］	Wang T, Chen D, Yang J, et al. Safety and efficacy of dual⁃wavelength laser （1064 + 595 nm） for treatment of non⁃treated port⁃wine stains［J］. J Eur Acad Dermatol Venereol, 2018,32（2）:260⁃264. doi: 10.1111/jdv.14490.
［53］	Tierney EP, Hanke CW. Alexandrite laser for the treatment of port wine stains refractory to pulsed dye laser［J］. Dermatol Surg, 2011,37（9）:1268⁃1278. doi: 10.1111/j.1524⁃4725.2011.02079.x.
［54］	Nguyen L, Seeber N, Kautz G, et al. 532⁃nm potassium titanyl⁃phosphate laser versus 595⁃nm pulsed dye laser for port⁃wine birthmarks: a prospective, randomized, split⁃side study［J］. J Eur Acad Dermatol Venereol, 2024,38（6）:1140⁃1146. doi: 10.1111/jdv.19750.
［55］	Al⁃Dhalimi MA, Al⁃Janabi MH. Split lesion randomized comparative study between long pulsed Nd:YAG laser 532 and 1,064 nm in treatment of facial port⁃wine stain［J］. Lasers Surg Med, 2016,48（9）:852⁃858. doi: 10.1002/lsm.22584.
［56］	Wang B, Wu Y, Zhu X, et al. Treatment of neck port⁃wine stain with intense pulsed light in Chinese population［J］. J Cosmet Laser Ther, 2013,15（2）:85⁃90. doi: 10.3109/14764172.2012. 748204.
［57］	Raulin C, Schroeter CA, Weiss RA, et al. Treatment of port⁃wine stains with a noncoherent pulsed light source: a retrospective study［J］. Arch Dermatol, 1999,135（6）:679⁃683. doi: 10.1001/archderm.135.6.679.
［58］	Sheng H, Zeng H, Zhang M. Comparing the therapeutic effect of pulsed dye laser and pulsed dye laser plus CO2 in port wine stain［J］. Postepy Dermatol Alergol, 2022,39（5）:923⁃927. doi: 10. 5114/ada.2022.119073.
［59］	Zhang T. Extended application of fractional carbon dioxide laser in the treatment of port wine stain birthmarks with hypertrophy: a case report［J］. Photobiomodul Photomed Laser Surg, 2023,41（4）:189⁃192. doi: 10.1089/photob.2022.0149.
［60］	Tierney EP, Hanke CW. Treatment of nodules associated with port wine stains with CO2 laser: case series and review of the literature［J］. J Drugs Dermatol, 2009,8（2）:157⁃161.
［61］	Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy［J］. J Natl Cancer Inst, 1998,90（12）:889⁃905. doi: 10. 1093/jnci/90.12.889.
［62］	刘凡光, 顾瑛, 富秋涛, 等. 光动力疗法治疗鲜红斑痣的基础研究——血啉甲醚与血卟啉衍生物吸收特性的比较［J］. 中国激光医学杂志, 2001,10（1）:9⁃12. doi: 10.3969/j.issn.1003⁃9430.2001.01.003.
［63］	Li⁃Qiang G, Hua W, Si⁃Li N, et al. A clinical study of HMME⁃PDT therapy in Chinese pediatric patients with port⁃wine stain［J］. Photodiagnosis Photodyn Ther, 2018,23:102⁃105. doi: 10. 1016/j.pdpdt.2018.06.006.
［64］	Zhang B, Zhang TH, Huang Z, et al. Comparison of pulsed dye laser （PDL） and photodynamic therapy （PDT） for treatment of facial port⁃wine stain （PWS） birthmarks in pediatric patients［J］. Photodiagnosis Photodyn Ther, 2014,11（4）:491⁃497. doi: 10.1016/j.pdpdt.2014.06.004.
［65］	Zhang Y, Yang Y, Zhang Z, et al. Clinical study on hemoporfin PDT for infant facial port⁃wine stains［J］. Photodiagnosis Photodyn Ther, 2019,25:106⁃110. doi: 10.1016/j.pdpdt.2018. 09.012.
［66］	Zhang LC, Yang J, Huang YB, et al. Efficacy of hemoporfin photodynamic therapy for pulsed dye laser⁃resistant facial port⁃wine stains in 107 children: a retrospective study［J］. Indian J Dermatol Venereol Leprol, 2022,88（2）:275. doi: 10.25259/IJDVL_976_20.
［67］	Zhang X, Yuan C, Xiao X, et al. Hemoporfin⁃mediated photodynamic therapy for the treatment of port⁃wine stain: a multicenter, retrospective study［J］. Photodiagnosis Photodyn Ther, 2023,42:103545. doi: 10.1016/j.pdpdt.2023.103545.
［68］	海姆泊芬光动力疗法治疗鲜红斑痣共识制订专家组. 海姆泊芬光动力疗法治疗鲜红斑痣专家共识（2024）［J］. 中华皮肤科杂志, 2024,57（7）:581⁃589. doi:10.35541/cjd.20230584.
［69］	Han Y, Ying H, Zhang X, et al. Retrospective study of photodynamic therapy for pulsed dye laser⁃resistant port⁃wine stains［J］. J Dermatol, 2020,47（4）:348⁃355. doi: 10.1111/1346⁃8138.15238.
［70］	Wang J, Zhu YY, Wang ZY, et al. Analysis of quality of life and influencing factors in 197 Chinese patients with port⁃wine stains［J］. Medicine （Baltimore）, 2017,96（51）:e9446. doi: 10.1097/MD.0000000000009446.

[1]	Bai Lu, Chu Yan, Liu Yuanyuan, Zhu Caiyong. Treatment of chronic hand eczema [J]. Chinese Journal of Dermatology, 2025, 58(5): 477-480.
[2]	Xiao Xing, Wang Shan, Yang Huan, Shu Hong, Guo Yanping, Chen Jinping, Lu Yao, Li Qinfeng, Liang Yuan, Zhao Mutong, Luo Xiaoyan, Miao Limin, Xu Rui, Li Xuemei, Lai Sha, Li Jianhong, Luo Zhen, Yu Lu, Xing Lu, Wang Meitan, Li Xiaoli, Xu Haitao, Li Ping, Wang Hua, Ma Lin. Comparison of efficacy and safety of crisaborole ointment 2% versus pimecrolimus cream 1% in the treatment of mild to moderate atopic dermatitis in children: a multicenter, randomized, controlled clinical trial [J]. Chinese Journal of Dermatology, 2025, 58(5): 425-430.
[3]	Deng Wei, Jiang Lixiao, Su Wei, Yang Zhou, Liu Xiaoyan, Zhang Gaolei. Clinical analysis of 15 cases of Mycoplasma pneumoniae-induced rash and mucositis [J]. Chinese Journal of Dermatology, 2025, 58(5): 460-463.
[4]	China Dermatologist Association, Treatment Group, Chinese Society of Dermatology, Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, National Clinical Research Center for Dermatologic and Immunologic Diseases, Rare Skin Diseases Committee, China Alliance for Rare Diseases. Diagnosis and treatment of bullous pemphigoid: an expert consensus statement （2025 edition） [J]. Chinese Journal of Dermatology, 2025, 58(5): 405-415.
[5]	Skin Cancer Research Group, Committee on Dermatology, Chinese Association of Integrative Medicine, Melanoma Society of China Anti-Cancer Association, Society of Integrated Rehabilitation of Skin Tumors, China Anti-Cancer Association. Expert consensus on diagnosis and treatment of pigmented nevi （2025 edition） [J]. Chinese Journal of Dermatology, 2025, 58(5): 387-395.
[6]	Li Ziyu, Lu Yan. Paying attention to severe skin diseases after COVID-19 [J]. Chinese Journal of Dermatology, 2025, 58(4): 378-383.
[7]	Xu Qiuyun, Ji Chao. Pyoderma gangrenosum-related systemic complications [J]. Chinese Journal of Dermatology, 2025, 58(4): 369-373.
[8]	Lyu Mingyue, Man Xiaoyong. Application of cell therapy in systemic lupus erythematosus [J]. Chinese Journal of Dermatology, 2025, 58(4): 374-377.
[9]	Wan Yongjun, Yang Haijing, Yan Qiao, Chen Mei, Wang Fengyuan, Su Qianya, Dong Zhengbang, Wang Fei. Clinical and prognostic analysis of nine cases of immune checkpoint inhibitor-related Stevens-Johnson syndrome/toxic epidermal necrolysis [J]. Chinese Journal of Dermatology, 2025, 58(4): 347-351.
[10]	Group on Pediatric Dermatology, China Dermatologist Association, Committee on Psoriasis, Chinese Society of Dermatology. Expert consensus on the diagnosis and treatment of pediatric pustular psoriasis in China （2025 version） [J]. Chinese Journal of Dermatology, 2025, 58(4): 297-306.
[11]	Chinese Society of Dermatology, China Dermatologist Association, Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, Rare Skin Diseases Committee, China Alliance for Rare Diseases, National Clinical Research Center for Dermatologic and Immunologic Diseases. Expert consensus on the diagnosis and treatment of paraneoplastic pemphigus in China （2025 version） [J]. Chinese Journal of Dermatology, 2025, 58(4): 289-296.
[12]	Group on Children, Chinese Society of Dermatology, Dermatology and Venereology Group, Chinese Pediatric Society, Chinese Medical Association, Chinese Association of Rehabilitation Dermatology, Pediatric Dermatology Group, China Dermatologist Association. Expert consensus on the construction of specialized outpatient clinics and standardized case management of children with atopic dermatitis in China （2025 version） [J]. Chinese Journal of Dermatology, 2025, 0(4): 20240338-e20240338.
[13]	Qin Bei, Li Qinfeng. Blueberry muffin baby: advances in the etiology [J]. Chinese Journal of Dermatology, 2025, 0(3): 20220411-e20220411.
[14]	Xu Zhuohong, Hu Yu, Gu Heng. Role of mesenchymal stem cell-derived exosomes in skin diseases [J]. Chinese Journal of Dermatology, 2025, 0(3): 20220881-e20220881.
[15]	Ye Hui, Deng Shilin, Liang Jingyao, Zhang Xibao. Correlations between the control of atopic dermatitis recurrence and tissue-resident memory T cells [J]. Chinese Journal of Dermatology, 2025, 0(3): 20240192-e20240192.

Expert consensus on diagnosis and treatment of port-wine stain in children （2025 edition）

PDF

Knowledge

Abstract

Cite this article

share this article

References ［70］

Related Articles 15

Metrics

Comments

Recommended 0